|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 299.20 DKK | +0.91% |
|
+1.25% | -8.01% |
| 15/05 | European Equities Traded in the US as American Depositary Receipts Down Sharply in Friday Trading | MT |
| 15/05 | Sandoz Lands EU Nod for Insulin Biosimilars Bysumlog, Dazparda | MT |
| Capitalization | 1,32600Cr 21TCr 18TCr 16TCr 15TCr 28TCr 19,79000Cr 29TCr 1,94700Cr 75TCr 9,39500Cr 77TCr 76TCr 32,73100Cr | P/E ratio 2026 * |
13.5x | P/E ratio 2027 * | 14.1x |
|---|---|---|---|---|---|
| Enterprise value | 1,44500Cr 22TCr 19TCr 18TCr 17TCr 31TCr 21,55500Cr 31TCr 2,12100Cr 82TCr 10,23200Cr 84TCr 83TCr 35,64900Cr | EV / Sales 2026 * |
4.96x | EV / Sales 2027 * | 4.82x |
| Free-Float |
71.44% | Yield 2026 * |
3.73% | Yield 2027 * | 3.64% |
Last Transcript: Novo Nordisk A/S
Trading Novo Nordisk A/S
| 1 day | +0.91% | ||
| 1 week | +1.25% | ||
| Current month | +9.90% | ||
| 1 month | +21.55% | ||
| 3 months | -3.67% | ||
| 6 months | -3.81% | ||
| Current year | -8.01% |
| 1 week | 293 |  | 306.15 |
| 1 month | 243.95 | | 312.05 |
| Current year | 224.25 | | 409.95 |
| 1 year | 224.25 | | 533.4 |
| 3 years | 224.25 | | 1,033.2 |
| 5 years | 224.25 | | 1,033.2 |
| 10 years | 109.1 | | 1,033.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 07/08/2025 | |
| Director of Finance/CFO | 55 | 15/02/2018 | |
Martin Lange
CTO | Chief Tech/Sci/R&D Officer | 56 | 07/08/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Kasim Kutay
BRD | Director/Board Member | 61 | 23/03/2017 |
| Director/Board Member | 51 | 22/03/2018 | |
| Director/Board Member | 61 | 24/03/2022 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +5.66% | 5.4% | 27 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.91% | +1.25% | -30.88% | -49.10% | 21TCr | |
| -0.00% | +3.07% | +40.44% | +131.32% | 90TCr | |
| -1.77% | +1.89% | +54.90% | +41.01% | 56TCr | |
| -0.18% | +3.79% | +18.57% | +42.98% | 37TCr | |
| +0.88% | +1.41% | +26.84% | +13.36% | 33TCr | |
| -0.79% | +2.39% | +36.02% | +13.51% | 29TCr | |
| -0.10% | +2.98% | +30.60% | +26.10% | 28TCr | |
| -1.79% | -0.82% | +51.60% | -4.92% | 28TCr | |
| -2.22% | -0.84% | +24.41% | +40.08% | 18TCr | |
| -1.88% | -3.34% | +31.71% | +65.77% | 16TCr | |
| Average | -0.17% | +2.02% | +28.42% | +32.01% | 35.56TCr | |
| Weighted average by Cap. | +0.24% | +2.44% | +33.52% | +50.29% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 29TCr 4.53TCr 3.9TCr 3.56TCr 3.4TCr 6.23TCr 4,34600Cr 6.34TCr 43TCr 17TCr 2,06300Cr 17TCr 17TCr 7,18800Cr | 30TCr 4.65TCr 4TCr 3.66TCr 3.49TCr 6.4TCr 4,45900Cr 6.5TCr 44TCr 17TCr 2,11700Cr 17TCr 17TCr 7,37500Cr |
| Net income | 9.71TCr 1.51TCr 1.3TCr 1.19TCr 1.13TCr 2.08TCr 1,44900Cr 2.11TCr 14TCr 5.52TCr 69TCr 5.67TCr 5.55TCr 2,39600Cr | 9.46TCr 1.47TCr 1.27TCr 1.16TCr 1.1TCr 2.03TCr 1,41200Cr 2.06TCr 14TCr 5.38TCr 67TCr 5.52TCr 5.4TCr 2,33500Cr |
| Net Debt | 12TCr 1.84TCr 1.58TCr 1.45TCr 1.38TCr 2.53TCr 1,76400Cr 2.57TCr 17TCr 6.72TCr 84TCr 6.9TCr 6.75TCr 2,91800Cr | 11TCr 1.76TCr 1.52TCr 1.39TCr 1.32TCr 2.42TCr 1,68900Cr 2.46TCr 17TCr 6.43TCr 80TCr 6.61TCr 6.47TCr 2,79400Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/26/13 | 299.20 kr | +0.91% | 54,00,168 |
| 12/26/12 | 296.50 kr | -1.17% | 58,34,172 |
| 11/26/11 | 300.00 kr | +3.34% | 72,78,350 |
| 08/26/08 | 290.30 kr | -1.76% | 46,14,317 |
| 07/26/07 | 295.50 kr | +0.85% | 55,30,016 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- NOVO B Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition